Merck & Co., Inc. is 59.1x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($293.16 B vs $4.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | XENE | MRK |
|---|---|---|
| Market cap | $4.96 B | $293.16 B |
| US-listed rank | #1390 | #44 |
| Revenue (latest FY) | $311.00K | $65.01B |
| Net income (latest FY) | -$345.91M | $18.25B |
| Net margin | -111225.1% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 763 | 996 |
Merck & Co., Inc. is 59.1x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($293.16 B vs $4.96 B).
In their latest fiscal years, Xenon Pharmaceuticals Inc. reported $311.00K in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Xenon Pharmaceuticals Inc. and Merck & Co., Inc., or browse the full rankings.